Infectious Disease ConsultantMayo ClinicRochester, Minnesota, United States
AbbVie (Consultant)
40 - Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial
On Demand